• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人血浆淀粉样蛋白-β寡聚化与θ/β比值的关联。

Association of plasma amyloid-β oligomerization with theta/beta ratio in older adults.

作者信息

Bae Heewon, Kang Min Ju, Ha Sang-Won, Jeong Da-Eun, Lee Kiwon, Lim Seungui, Min Jin-Young, Min Kyoung-Bok

机构信息

Veterans Medical Research Institute, Veterans Health Service Medical Center, Seoul, Republic of Korea.

Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea.

出版信息

Front Aging Neurosci. 2023 Dec 1;15:1291881. doi: 10.3389/fnagi.2023.1291881. eCollection 2023.

DOI:10.3389/fnagi.2023.1291881
PMID:38106526
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10722169/
Abstract

BACKGROUND

Oligomeric Aβ (OAβ) is a promising candidate marker for Alzheimer's disease (AD) diagnosis. Electroencephalography (EEG) is a potential tool for early detection of AD. Still, whether EEG power ratios, particularly the theta/alpha ratio (TAR) and theta/beta ratio (TBR), reflect Aβ burden-a primary mechanism underlying cognitive impairment and AD. This study investigated the association of TAR and TBR with amyloid burden in older adults based on MDS-OAβ levels.

METHODS

529 individuals (aged ≥60 years) were recruited. All participants underwent EEG (MINDD SCAN, Ybrain Inc., South Korea) and AlzOn™ test (PeopleBio Inc., Gyeonggi-do, Republic of Korea) for quantifying MDS-OAβ values in the plasma. EEG variables were log-transformed to normalize the data distribution. Using the MDS-OAβ cutoff value (0.78 ng/mL), all participants were classified into two groups: high MDS-OAβ and low MDS-OAβ.

RESULTS

Participants with high MDS-OAβ levels had significantly higher TARs and TBRs than those with low MDS-OAβ levels. The log-transformed TBRs in the central lobe (β = 0.161,  = 0.0026), frontal lobe (β = 0.145,  = 0.0044), parietal lobe (β = 0.166,  = 0.0028), occipital lobe (β = 0.158,  = 0.0058), and temporal lobe (beta = 0.162,  = 0.0042) were significantly and positively associated with increases in MDS-OAβ levels. After adjusting for the Bonferroni correction, the TBRs in all lobe regions, except the occipital lobe, were significantly associated with increased MDS-OAβ levels.

CONCLUSION

We found a significant association of MDS-OAβ with TBR in older adults. This finding indicates that an increase in amyloid burden may be associated with an increase in the low-frequency band and a decrease in the relatively high-frequency band.

摘要

背景

寡聚β淀粉样蛋白(OAβ)是阿尔茨海默病(AD)诊断中一个很有前景的候选标志物。脑电图(EEG)是早期检测AD的一种潜在工具。然而,EEG功率比,特别是θ/α比值(TAR)和θ/β比值(TBR)是否反映β淀粉样蛋白负担——认知障碍和AD的一个主要潜在机制。本研究基于MDS - OAβ水平调查了老年人中TAR和TBR与淀粉样蛋白负担的关联。

方法

招募了529名个体(年龄≥60岁)。所有参与者均接受了脑电图检查(MINDD SCAN,韩国Ybrain公司)和AlzOn™检测(韩国京畿道PeopleBio公司),以定量血浆中的MDS - OAβ值。对EEG变量进行对数转换以标准化数据分布。使用MDS - OAβ临界值(0.78 ng/mL),将所有参与者分为两组:高MDS - OAβ组和低MDS - OAβ组。

结果

MDS - OAβ水平高的参与者的TAR和TBR显著高于MDS - OAβ水平低的参与者。中央叶(β = 0.161,P = 0.0026)、额叶(β = 0.145,P = 0.0044)、顶叶(β = 0.166,P = 0.0028)、枕叶(β = 0.158,P = 0.0058)和颞叶(β = 0.162,P = 0.0042)的对数转换后的TBR与MDS - OAβ水平的升高显著正相关。在进行Bonferroni校正后,除枕叶外,所有叶区域的TBR均与MDS - OAβ水平升高显著相关。

结论

我们发现老年人中MDS - OAβ与TBR之间存在显著关联。这一发现表明淀粉样蛋白负担的增加可能与低频带的增加和相对高频带的减少有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb55/10722169/5b006cb53a22/fnagi-15-1291881-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb55/10722169/5b006cb53a22/fnagi-15-1291881-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb55/10722169/5b006cb53a22/fnagi-15-1291881-g001.jpg

相似文献

1
Association of plasma amyloid-β oligomerization with theta/beta ratio in older adults.老年人血浆淀粉样蛋白-β寡聚化与θ/β比值的关联。
Front Aging Neurosci. 2023 Dec 1;15:1291881. doi: 10.3389/fnagi.2023.1291881. eCollection 2023.
2
Plasma Oligomer β-Amyloid and White Matter Microstructural Integrity in Cognitively Normal Older Adults According to Cerebral Amyloid Deposition.根据脑淀粉样蛋白沉积情况,在认知正常的老年人群中,血浆寡聚β-淀粉样蛋白与脑白质微观结构完整性的关系。
J Prev Alzheimers Dis. 2023;10(4):837-846. doi: 10.14283/jpad.2023.87.
3
Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer's disease spectrum.血浆寡聚β-淀粉样蛋白与阿尔茨海默病谱系中的疾病严重程度和脑淀粉样蛋白沉积相关。
Alzheimers Res Ther. 2024 Mar 11;16(1):55. doi: 10.1186/s13195-024-01400-3.
4
Reference interval and the role of plasma oligomeric beta amyloid in screening of risk groups for cognitive dysfunction at health checkups.参考区间和血浆寡聚β淀粉样蛋白在健康体检中认知功能障碍风险人群筛查中的作用。
J Clin Lab Anal. 2021 Sep;35(9):e23933. doi: 10.1002/jcla.23933. Epub 2021 Aug 3.
5
Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity.血浆淀粉样蛋白-β寡聚倾向预测淀粉样 PET 阳性。
Clin Interv Aging. 2021 Apr 30;16:749-755. doi: 10.2147/CIA.S312473. eCollection 2021.
6
Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer's disease.血浆中淀粉样β寡聚体水平升高与阿尔茨海默病的情景记忆丧失有关。
Alzheimers Res Ther. 2019 Oct 25;11(1):89. doi: 10.1186/s13195-019-0535-7.
7
Blood Amyloid-β Oligomerization as a Biomarker of Alzheimer's Disease: A Blinded Validation Study.血液淀粉样-β寡聚体作为阿尔茨海默病的生物标志物:一项盲法验证研究。
J Alzheimers Dis. 2020;75(2):493-499. doi: 10.3233/JAD-200061.
8
Multimer Detection System-Oligomerized Amyloid Beta (MDS-OA): A Plasma-Based Biomarker Differentiates Alzheimer's Disease from Other Etiologies of Dementia.多聚体检测系统 - 寡聚化β淀粉样蛋白(MDS - OA):一种基于血浆的生物标志物可区分阿尔茨海默病与其他痴呆病因。
Int J Alzheimers Dis. 2022 May 2;2022:9960832. doi: 10.1155/2022/9960832. eCollection 2022.
9
Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status.血浆淀粉样蛋白-β寡聚体分析作为淀粉样状态的预筛选测试。
Alzheimers Res Ther. 2021 Jul 26;13(1):133. doi: 10.1186/s13195-021-00873-w.
10
Implication of EEG theta/alpha and theta/beta ratio in Alzheimer's and Lewy body disease.脑电图θ/α 和 θ/β 比值在阿尔茨海默病和路易体病中的意义。
Sci Rep. 2022 Nov 4;12(1):18706. doi: 10.1038/s41598-022-21951-5.

引用本文的文献

1
Identification of cerebrospinal fluid pharmacodynamic biomarkers and molecular correlates of brain activity in a Phase 2 clinical trial of the Alzheimer's disease drug candidate CT1812.在阿尔茨海默病候选药物CT1812的2期临床试验中脑脊液药效学生物标志物的鉴定及大脑活动的分子关联
Alzheimers Dement (N Y). 2025 Jun 19;11(2):e70119. doi: 10.1002/trc2.70119. eCollection 2025 Apr-Jun.
2
Diagnostic Performance of Eight Blood-based Biomarkers in a Well-characterized Korean Cohort of Preclinical Alzheimer's Disease.八项血液生物标志物在特征明确的韩国临床前阿尔茨海默病队列中的诊断性能
Ann Lab Med. 2025 May 12. doi: 10.3343/alm.2024.0498.
3

本文引用的文献

1
Plasma amyloid-beta oligomer is related to subjective cognitive decline and brain amyloid status.血浆淀粉样β寡聚体与主观认知下降和脑淀粉样状态有关。
Alzheimers Res Ther. 2022 Nov 3;14(1):162. doi: 10.1186/s13195-022-01104-6.
2
Use of electroencephalogram, gait, and their combined signals for classifying cognitive impairment and normal cognition.使用脑电图、步态及其组合信号对认知障碍和正常认知进行分类。
Front Aging Neurosci. 2022 Sep 7;14:927295. doi: 10.3389/fnagi.2022.927295. eCollection 2022.
3
Theta Band-Power Shapes Amyloid-Driven Longitudinal EEG Changes in Elderly Subjective Memory Complainers At-Risk for Alzheimer's Disease.
A Pilot Electroencephalography Study of the Effect of CT1812 Treatment on Synaptic Activity in Patients with Mild to Moderate Alzheimer's Disease.
一项 CT1812 治疗对轻度至中度阿尔茨海默病患者突触活性影响的脑电图先导研究。
J Prev Alzheimers Dis. 2024;11(6):1809-1817. doi: 10.14283/jpad.2024.154.
theta 波段功率塑造了阿尔茨海默病风险的老年主观记忆抱怨者的淀粉样蛋白驱动的纵向 EEG 变化。
J Alzheimers Dis. 2022;90(1):69-84. doi: 10.3233/JAD-220204.
4
Altered excitatory and inhibitory neuronal subpopulation parameters are distinctly associated with tau and amyloid in Alzheimer's disease.阿尔茨海默病中,兴奋性和抑制性神经元亚群参数的改变与tau 和淀粉样蛋白明显相关。
Elife. 2022 May 26;11:e77850. doi: 10.7554/eLife.77850.
5
Multimer Detection System-Oligomerized Amyloid Beta (MDS-OA): A Plasma-Based Biomarker Differentiates Alzheimer's Disease from Other Etiologies of Dementia.多聚体检测系统 - 寡聚化β淀粉样蛋白(MDS - OA):一种基于血浆的生物标志物可区分阿尔茨海默病与其他痴呆病因。
Int J Alzheimers Dis. 2022 May 2;2022:9960832. doi: 10.1155/2022/9960832. eCollection 2022.
6
Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status.血浆淀粉样蛋白-β寡聚体分析作为淀粉样状态的预筛选测试。
Alzheimers Res Ther. 2021 Jul 26;13(1):133. doi: 10.1186/s13195-021-00873-w.
7
Resting-state EEG alpha/theta power ratio discriminates early-onset Alzheimer's disease from healthy controls.静息态 EEGα/θ功率比可区分早发性阿尔茨海默病与健康对照。
Clin Neurophysiol. 2021 Sep;132(9):2019-2031. doi: 10.1016/j.clinph.2021.05.012. Epub 2021 Jun 6.
8
Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer's Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression.神经毒性可溶性淀粉样寡聚体驱动阿尔茨海默病的发病机制,代表了一种经过临床验证的可减缓疾病进展的目标。
Int J Mol Sci. 2021 Jun 14;22(12):6355. doi: 10.3390/ijms22126355.
9
Dynamic theta/beta ratio of clinical EEG in Alzheimer's disease.阿尔茨海默病临床脑电图的动态θ/β 比值。
J Neurosci Methods. 2021 Jul 15;359:109219. doi: 10.1016/j.jneumeth.2021.109219. Epub 2021 May 23.
10
P-tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status.脑脊液中P- tau/Aβ42和Aβ42/40的比值对淀粉样蛋白PET状态具有同等的预测价值。
Alzheimers Dement (Amst). 2021 May 18;13(1):e12190. doi: 10.1002/dad2.12190. eCollection 2021.